Medreich
Bengaluru, India· Est.
Integrated Indian CDMO delivering full‑cycle small‑molecule drug development and manufacturing services.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated Indian CDMO delivering full‑cycle small‑molecule drug development and manufacturing services.
General MedicineOncologyCardiovascularCentral Nervous System
Technology Platform
Integrated end‑to‑end small‑molecule formulation and manufacturing platform with state‑of‑the‑art facilities for API synthesis, dosage‑form development, analytical testing, and GMP production.
Opportunities
Rising demand for outsourced drug development and niche generic manufacturing, plus geographic expansion into regulated markets.
Risk Factors
Intense competition from global CDMOs, regulatory compliance pressures, and need for continuous technology investment.
Competitive Landscape
Competes with large CDMOs such as Lonza, Catalent, and Patheon; differentiates through cost‑effective Indian manufacturing and focus on small‑molecule niche generics.